ID: ALA3577192

Max Phase: Preclinical

Molecular Formula: C21H22O6

Molecular Weight: 370.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=CC[C@]12C[C@@]3(OCOC3=CC1=O)[C@H](C)[C@@H]2c1cc(OC)c2c(c1)OCO2

Standard InChI:  InChI=1S/C21H22O6/c1-4-5-20-9-21(17(8-16(20)22)25-11-27-21)12(2)18(20)13-6-14(23-3)19-15(7-13)24-10-26-19/h4,6-8,12,18H,1,5,9-11H2,2-3H3/t12-,18-,20+,21-/m1/s1

Standard InChI Key:  VMBFNOIPGQFDTB-XFHMVGKKSA-N

Associated Targets(Human)

A2780 11979 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Aedes aegypti 630 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasmodium falciparum 966862 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 370.40Molecular Weight (Monoisotopic): 370.1416AlogP: 3.32#Rotatable Bonds: 4
Polar Surface Area: 63.22Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.11CX LogD: 3.11
Aromatic Rings: 1Heavy Atoms: 27QED Weighted: 0.76Np Likeness Score: 2.26

References

1. Rakotondraibe LH, Graupner PR, Xiong Q, Olson M, Wiley JD, Krai P, Brodie PJ, Callmander MW, Rakotobe E, Ratovoson F, Rasamison VE, Cassera MB, Hahn DR, Kingston DG, Fotso S..  (2015)  Neolignans and other metabolites from Ocotea cymosa from the Madagascar rain forest and their biological activities.,  78  (3): [PMID:25650896] [10.1021/np5008153]

Source